On March 17, 2026, Iovance Biotherapeutics, Inc. announced that Wendy Yarno, a member of its Board of Directors, has decided to retire and will not stand for re-election at the upcoming annual meeting of stockholders scheduled for June 2026. Ms. Yarno will fulfill her current term until the Annual Meeting. The company clarified that her decision to retire is not due to any disagreements regarding the company's operations, policies, or practices. Iovance Biotherapeutics expressed gratitude for Ms. Yarno's contributions during her tenure on the Board. This change in leadership is part of the company's ongoing governance practices, ensuring that the Board remains effective and aligned with the company's strategic goals.



Press Release distribution
National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.